Matsumoto M, Schmitz J A, Syuto B, Watrous B J, Mattson D E
Vet Res Commun. 1984 May;8(2):117-30. doi: 10.1007/BF02214703.
Three experiments were performed to evaluate the immunogenic potency of a soluble fraction of Pasteurella haemolytica against pneumonic pasteurellosis in calves. A soluble antigen was extracted by a 2.5% saline solution from P. haemolytica. Weaned Holstein bull calves, seronegative for infectious bovine rhinotracheitis virus ( IBRV ) and the pasteurella antigen, were vaccinated either by repeated subcutaneous (SC) vaccination, or by exposure 3 times to the aerosol of P. haemolytica antigen. Challenge exposure to aerosol of P. haemolytica was preceded by infection with IBRV , or in experiments 2 and 3, the virus exposures were combined with a stress treatment. The lung lesions were examined at necropsy 3 to 8 days post infection. In the first experiment, all the vaccinated calves produced specific antibody response to the pasteurella antigen, and none of the calves including controls showed significant lesions in the lung. In the second experiment 2 aerogenically vaccinated calves had no lesions. One of the two SC-vaccinated calves had mild consolidated lesions. Two control calves, one of which died 3 days following the challenge, developed severe fibrinous pneumonia with consolidation of 50% or more of the lung surfaces. P. haemolytica was isolated only from the 2 control animals. In the third experiment, 2 of the 3 control calves developed moderate to severe consolidation, but P. haemolytica was isolated only from one of them. Two of the three aerosol-vaccinated calves also developed significant lesions and one of them yielded the bacteria from the lung. Three SC-vaccinated calves had slight lesions and the organism was not isolated from their lungs. The results did not consistently indicate an immunogenic potential of the soluble antigen against P. haemolytica-related pneumonia. The effect of stress on the pathogenesis of bovine viral pneumonia and correlation between pneumonic lesions and antibacterial resistance in situ are discussed.
进行了三项实验,以评估溶血巴斯德菌可溶性组分对犊牛肺炎性巴氏杆菌病的免疫原性效力。用2.5%的盐溶液从溶血巴斯德菌中提取可溶性抗原。对感染牛传染性鼻气管炎病毒(IBRV)和巴氏杆菌抗原呈血清阴性的断奶荷斯坦公牛犊,通过重复皮下(SC)接种或3次暴露于溶血巴斯德菌抗原气雾剂进行接种。在暴露于溶血巴斯德菌气雾剂进行攻毒之前,先感染IBRV,或者在实验2和3中,将病毒暴露与应激处理相结合。在感染后3至8天进行尸检,检查肺部病变。在第一个实验中,所有接种疫苗的犊牛都对巴氏杆菌抗原产生了特异性抗体反应,包括对照组在内的所有犊牛肺部均未出现明显病变。在第二个实验中,2头经气雾剂接种的犊牛没有病变。2头经皮下接种的犊牛中有1头有轻度实变病变。2头对照犊牛,其中1头在攻毒后3天死亡,发生了严重的纤维素性肺炎,肺部表面实变达50%或更多。仅从2头对照动物中分离出溶血巴斯德菌。在第三个实验中,3头对照犊牛中有2头出现中度至重度实变,但仅从其中1头分离出溶血巴斯德菌。3头经气雾剂接种的犊牛中有2头也出现了明显病变,其中1头从肺部分离出了细菌。3头经皮下接种的犊牛有轻微病变,且未从其肺部分离出该菌。结果并不一致地表明可溶性抗原对溶血巴斯德菌相关肺炎具有免疫原性潜力。讨论了应激对牛病毒性肺炎发病机制的影响以及肺部病变与原位抗菌耐药性之间的相关性。